AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
NATURAL-HISTORY OF EPITHELIAL OVARIAN-CANCER - FROM EPIDEMIOLOGY TO EXPERIMENTATION
Authors: HAMILTON TC PENAULTLLORCA F DAUPLAT J
Citation: Tc. Hamilton et al., NATURAL-HISTORY OF EPITHELIAL OVARIAN-CANCER - FROM EPIDEMIOLOGY TO EXPERIMENTATION, Contraception fertilite sexualite, 26(11), 1998, pp. 800-804
MICROINVASIVE CARCINOMA OF THE BREAST - IS AXILLARY LYMPH-NODE DISSECTION INDICATED
Authors: PENAULTLLORCA F LEBOUEDEC G POMEL C FEILLEL V DAUPLAT J DELATOUR M
Citation: F. Penaultllorca et al., MICROINVASIVE CARCINOMA OF THE BREAST - IS AXILLARY LYMPH-NODE DISSECTION INDICATED, European journal of cancer, 34, 1998, pp. 204-204
EXPRESSION OF CYTOSOLIC THYMIDINE KINASE IN THE PROLIFERATIVE BREAST-CARCINOMA AFTER PRIMARY CHEMOTHERAPY - THERAPEUTIC INDICATION
Authors: GACHON F CHARRIER S KWIATKOWSKI F BESSE G CURE H CHASSAGNE J FERRIERE JP PENAULTLLORCA F DAUPLAT J CHOLLET P
Citation: F. Gachon et al., EXPRESSION OF CYTOSOLIC THYMIDINE KINASE IN THE PROLIFERATIVE BREAST-CARCINOMA AFTER PRIMARY CHEMOTHERAPY - THERAPEUTIC INDICATION, European journal of cancer, 34, 1998, pp. 469-469
TAMOXIFEN AND UTERINE FIBROIDS
Authors: LEBOUEDEC G DELATOUR M DAUPLAT J
Citation: G. Lebouedec et al., TAMOXIFEN AND UTERINE FIBROIDS, European journal of cancer, 34, 1998, pp. 19-21
RISK-FACTORS OF LOCAL RECURRENCE IN WOMEN WITH DUCTAL CARCINOMA IN-SITU (DCIS) ACCORDING TO THE TREATMENT
Authors: AUVRAY H PENAULTLLORCA F DELATOUR M DAUPLAT J ACHARD JL LEBOUEDEC G
Citation: H. Auvray et al., RISK-FACTORS OF LOCAL RECURRENCE IN WOMEN WITH DUCTAL CARCINOMA IN-SITU (DCIS) ACCORDING TO THE TREATMENT, European journal of cancer, 34, 1998, pp. 57-57
RECOMMENDATIONS FOR MEDICAL-MANAGEMENT OF HEREDITARY BREAST AND OVARIAN-CANCER - THE FRENCH NATIONAL AD HOC COMMITTEE
Authors: EISINGER F ALBY N BREMOND A DAUPLAT J ESPIE M JANIAUD P KUTTENN F LEBRUN JP LEFRANC JP PIERRET J SOBOL H STOPPALYONNET D THOUVENIN D TRISTANT H FEINGOLD J
Citation: F. Eisinger et al., RECOMMENDATIONS FOR MEDICAL-MANAGEMENT OF HEREDITARY BREAST AND OVARIAN-CANCER - THE FRENCH NATIONAL AD HOC COMMITTEE, Annals of oncology, 9(9), 1998, pp. 939-950
MICROINVASIVE CARCINOMA OF THE BREAST - IS AXILLARY LYMPH-NODE DISSECTION INDICATED
Authors: PENAULTLLORCA F LEBOUEDEC G POMEL C FEILLEL V DAUPLAT J DELATOUR M
Citation: F. Penaultllorca et al., MICROINVASIVE CARCINOMA OF THE BREAST - IS AXILLARY LYMPH-NODE DISSECTION INDICATED, Modern pathology, 11(1), 1998, pp. 25-25
PRIMARY CHEMOTHERAPY IN BREAST-CANCER - CORRELATION BETWEEN TUMOR RESPONSE AND PATIENT OUTCOME
Authors: FERRIERE JP ASSIER I CURE H CHARRIER S KWIATKOWSKI F ACHARD JL DAUPLAT J CHOLLET P
Citation: Jp. Ferriere et al., PRIMARY CHEMOTHERAPY IN BREAST-CANCER - CORRELATION BETWEEN TUMOR RESPONSE AND PATIENT OUTCOME, American journal of clinical oncology, 21(2), 1998, pp. 117-120
INTESTINAL PERFORATION COMPLICATING PRIMA RY CYTOMEGALOVIRUS-INFECTION IN A PATIENT RECEIVING TREATMENT FOR TESTICULAR CANCER
Authors: BEAL D BAY JO LEBOUEDEC G FERNANDEZ M CONDAT P DAUPLAT J PLAGNE R
Citation: D. Beal et al., INTESTINAL PERFORATION COMPLICATING PRIMA RY CYTOMEGALOVIRUS-INFECTION IN A PATIENT RECEIVING TREATMENT FOR TESTICULAR CANCER, La Semaine des hopitaux de Paris, 74(11-12), 1998, pp. 594-597
MICROINVASIVE CARCINOMA OF THE BREAST - IS AXILLARY LYMPH-NODE DISSECTION INDICATED
Authors: PENAULTLLORCA F LEBOUEDEC G POMEL C FEILLEL V DAUPLAT J DELATOUR M
Citation: F. Penaultllorca et al., MICROINVASIVE CARCINOMA OF THE BREAST - IS AXILLARY LYMPH-NODE DISSECTION INDICATED, Laboratory investigation, 78(1), 1998, pp. 125-125
OPTIMAL DURATION OF NEOADJUVANT CHEMOTHERAPY - 3 OR 4 VERSUS 6 CYCLESIN 3 SCHEMES FOR OPERABLE BREAST-CANCER
Authors: CHARRIER S FERRIERE JP KWIATKOWSKI F CURE H VANPRAAGH I FEILLEL V ASSIER I BAY JO DAUPLAT J CHOLLET P
Citation: S. Charrier et al., OPTIMAL DURATION OF NEOADJUVANT CHEMOTHERAPY - 3 OR 4 VERSUS 6 CYCLESIN 3 SCHEMES FOR OPERABLE BREAST-CANCER, European journal of cancer, 33, 1997, pp. 360-360
CLINICAL AND PATHOLOGICAL RESPONSE TO PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER
Authors: CHOLLET P CHARRIER S BRAIN E CURE H VANPRAAGH I FEILLEL V DELATOUR M DAUPLAT J MISSET JL FERRIERE JP
Citation: P. Chollet et al., CLINICAL AND PATHOLOGICAL RESPONSE TO PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER, European journal of cancer, 33(6), 1997, pp. 862-866
SISTER-MARIE-JOSEPH-NODULE
Authors: LEBOUEDEC G BEAL D BUSSEROLLESFERNANDEZ M LESCURE G DAUPLAT J
Citation: G. Lebouedec et al., SISTER-MARIE-JOSEPH-NODULE, La Presse medicale, 26(19), 1997, pp. 903-903
OVARIAN-CARCINOMA MUCOCELLULAR (KRUKENBER GS TUMOR) - 10 CASES OF BREAST-CANCER METASTASIS
Authors: LEBOUEDEC G DELATOUR M LEVREL O DAUPLAT J
Citation: G. Lebouedec et al., OVARIAN-CARCINOMA MUCOCELLULAR (KRUKENBER GS TUMOR) - 10 CASES OF BREAST-CANCER METASTASIS, La Presse medicale, 26(10), 1997, pp. 454-457
HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC RESCUE IN PATIENTS WITH STAGE-III TO STAGE-IV OVARIAN-CANCER - LONG-TERM RESULTS
Authors: LEGROS M DAUPLAT J FLEURY J CURE H SUZANNE F CHASSAGNE J BAY JO SOL C CANIS M CONDAT P CHOUFI B TAVERNIER F GLENAT C CHOLLET P PLAGNE R
Citation: M. Legros et al., HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC RESCUE IN PATIENTS WITH STAGE-III TO STAGE-IV OVARIAN-CANCER - LONG-TERM RESULTS, Journal of clinical oncology, 15(4), 1997, pp. 1302-1308
ADJUVANT CHEMOTHERAPY WITH DOXORUBICIN-CONTAINING REGIMEN FOR 326 STAGE-II BREAST CANCERS - 15-YEAR RESULTS
Authors: FERRIERE JP CHARRIER S CURE H KWIATKOWSKI F COURTADON M BELEMBAOGO E DELATOUR M ACHARD JL DAUPLAT J CHOLLET P
Citation: Jp. Ferriere et al., ADJUVANT CHEMOTHERAPY WITH DOXORUBICIN-CONTAINING REGIMEN FOR 326 STAGE-II BREAST CANCERS - 15-YEAR RESULTS, American journal of clinical oncology, 20(3), 1997, pp. 219-225
EPIDURAL METASTASIS AND TUMOR INVASION OF THE LEFT RENAL-VEIN
Authors: BAILLY C PTAK Y VINCENT C RONAYETTE H LEMERY S DAUPLAT J
Citation: C. Bailly et al., EPIDURAL METASTASIS AND TUMOR INVASION OF THE LEFT RENAL-VEIN, Journal de radiologie, 78(8), 1997, pp. 581-584
PERITONEAL TUBERCULOSIS WITH ELEVATION OF THE CA-125
Authors: LEBOUEDEC G DELATOUR MP DESAINTSALVY JC DAUPLAT J
Citation: G. Lebouedec et al., PERITONEAL TUBERCULOSIS WITH ELEVATION OF THE CA-125, La Semaine des hopitaux de Paris, 73(31-32), 1997, pp. 1005-1008
RESULTS OF 3 NEOADJUVANT CHEMOTHERAPY REG IMEN FOR OPERABLE BREAST-CANCER
Authors: CURE H CHARRIER S FERRIERE JP VANPRAAGH I ASSIER I FEILLEL V DELATOUR M BAY JO ACHARD JL DAUPLAT J CHOLLET P
Citation: H. Cure et al., RESULTS OF 3 NEOADJUVANT CHEMOTHERAPY REG IMEN FOR OPERABLE BREAST-CANCER, Bulletin du cancer, 84(1), 1997, pp. 31-34
INITIAL SURGERY FOR ADVANCED EPITHELIAL O VARIAN-CANCER
Authors: DAUPLAT J LEBOUEDEC G POMEL C KAUFFMANN P
Citation: J. Dauplat et al., INITIAL SURGERY FOR ADVANCED EPITHELIAL O VARIAN-CANCER, Annales de chirurgie, 51(10), 1997, pp. 1058-1068
GENETIC SEARCH IN SURGICAL INDICATIONS FO R CANCER
Authors: DAUPLAT J BIGNON YJ POMEL C LEBOUEDEC G BAY JO KAUFFMANN P DELATOUR M
Citation: J. Dauplat et al., GENETIC SEARCH IN SURGICAL INDICATIONS FO R CANCER, La Presse medicale, 25(34), 1996, pp. 1633-1635
TECHNETIUM-99M-SESTAMIBI UPTAKE IN BREAST-TUMOR AND ASSOCIATED LYMPH-NODES
Authors: MAUBLANT J DELATOUR M MESTAS D CLEMENSON A CHARRIER S FEILLEL V LEBOUEDEC G KAUFMANN P DAUPLAT J VEYRE A
Citation: J. Maublant et al., TECHNETIUM-99M-SESTAMIBI UPTAKE IN BREAST-TUMOR AND ASSOCIATED LYMPH-NODES, The Journal of nuclear medicine, 37(6), 1996, pp. 922-925
AXILLARY LYMPH-NODE DISSECTION IN NON-PAL PABLE BREAST CANCERS
Authors: LEBOUEDEC G POMEL C CHAMUSSY E FEILLEL V DELATOUR M DAUPLAT J
Citation: G. Lebouedec et al., AXILLARY LYMPH-NODE DISSECTION IN NON-PAL PABLE BREAST CANCERS, Bulletin du cancer, 83(7), 1996, pp. 581-588
ENDOMETRIAL CARCINOMA-ASSOCIATED WITH ADJUVANT TAMOXIFEN THERAPY FOR BREAST-CANCER - A FRENCH MULTICENTER ANALYSIS OF 89 CASES
Authors: MIGNOTTE H RODIER JF LESUR A HOFFSTETTER S CUTULI B DANJOU J ROUANET P LASRY S LEBOUEDEC G DAUPLAT J DEPADT G GIARD S FONDRINIER E
Citation: H. Mignotte et al., ENDOMETRIAL CARCINOMA-ASSOCIATED WITH ADJUVANT TAMOXIFEN THERAPY FOR BREAST-CANCER - A FRENCH MULTICENTER ANALYSIS OF 89 CASES, Breast, 4(3), 1995, pp. 200-202
COMPARISON OF 3 NEOADJUVANT CHEMOTHERAPY REGIMENS FOR OPERABLE BREAST-CANCER
Authors: VANPRAGGH I FERRIERE JP CURE H FEILLEL V LEBOUEDEC G DELATOUR M ROLHION C CHARRIER S ASSIER I MISSET JL DAUPLAT J CHOLLET P
Citation: I. Vanpraggh et al., COMPARISON OF 3 NEOADJUVANT CHEMOTHERAPY REGIMENS FOR OPERABLE BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 53-53
Risultati: 1-25 | 26-44